A clinical study of ZW 251 for Liver cancer
Latest Information Update: 28 Oct 2024
At a glance
- Drugs ZW 251 (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 28 Oct 2024 New trial record
- 25 Oct 2024 According to Zymeworks media release, company announced intention to submit an IND application for Liver cancer in 2H 2025